# Terminology - Onconova Implementation Guide v0.2.0

* [**Table of Contents**](toc.md)
* **Terminology**

## Terminology

# Value Sets

The following value sets have been defined for this implementation guide:

* [TNM Lymphatic Invasion Categories Value Set](ValueSet-onconova-tnm-lymphatic-invasion-categories.md) 
TNM Lymphatic Invasion Categories Value Set 

* [TNM Perineural Invasion Categories Value Set](ValueSet-onconova-tnm-perineural-invasion-categories.md) 
TNM Perineural Invasion Categories Value Set 

* [TNM Residual Tumor Categories Value Set](ValueSet-onconova-tnm-residual-tumor-categories.md) 
TNM Residual Tumor Categories Value Set 

* [Adjunctive Therapy Roles](ValueSet-onconova-vs-adjunctive-therapy-roles.md) 
Codes representing roles for adjunctive therapy in oncology. 

* [Adverse Event Mitigation Categories](ValueSet-onconova-vs-adverse-event-mitigation-categories.md) 
Categories of actions taken to mitigate or manage adverse events in oncology. 

* [Adverse Event Mitigation - Drugs](ValueSet-onconova-vs-adverse-event-mitigation-drugs.md) 
Drugs or medication categories used in the mitigation process of an adverse event. 

* [Adverse Event Mitigation - Management](ValueSet-onconova-vs-adverse-event-mitigation-managements.md) 
Classification of actions to mitigate adverse events affecting a patient's health. 

* [Adverse Event Mitigation - Procedures](ValueSet-onconova-vs-adverse-event-mitigation-procedures.md) 
Procedures undertaken to mitigate the impact of an adverse event on a patient's health. 

* [Adverse Event Mitigation - Treatment Adjustment](ValueSet-onconova-vs-adverse-event-mitigation-treatment-adjustments.md) 
Adjustments made to a patient's treatment plan in response to an adverse event. 

* [Amino Acid Change Type Value Set](ValueSet-onconova-vs-amino-acid-change-type.md) 
Amino acid change types due to a genomic variant. It constraints and expands the original[LOINC Answer List LL380-7](https://loinc.org/LL380-7/)to enforce Onconova-compatible codes 

* [Antineoplastic Agents](ValueSet-onconova-vs-antineoplastic-agents.md) 
A value set of antineoplastic agents. 

* [Cancer Imaging Methods](ValueSet-onconova-vs-cancer-imaging-methods.md) 
Codes representing various imaging methods used in cancer diagnosis and monitoring. 

* [Cancer Risk Assessment Methods](ValueSet-onconova-vs-cancer-risk-assessment-methods.md) 
A value set containing codes for various cancer risk assessment methods. 

* [Risk Assessment Values](ValueSet-onconova-vs-cancer-risk-assessment-values.md) 
A non-exhaustive value set containing codes that result from risk assessments, i.e., the risk level of the cancer. 

* [Cause of Death Value Set](ValueSet-onconova-vs-causes-of-death.md) 
The causes of death that are relevant for a cancer patient. 

* [Clinical Relevance Value Set](ValueSet-onconova-vs-clinical-relevance.md) 
Clinical relevance of a genomic variant 

* [Comorbidity Panels](ValueSet-onconova-vs-comorbidity-panels.md) 
A collection of comorbidity panels relevant to cancer patients. 

* [Consent Status Value Set](ValueSet-onconova-vs-consent-status.md) 
The consent status of a patient 

* [CTC Adverse Events](ValueSet-onconova-vs-ctc-adverse-events.md) 
Common Terminology Criteria for Adverse Events (CTCAE) is a standard classification and severity grading scale for adverse events in clinical trials and oncology practice. 

* [Coding DNA Change Type Value Set](ValueSet-onconova-vs-dna-change-type.md) 
Coding DNA change types due to a genomic variant. It constraints and expands the original[LOINC Answer List LL380-7](https://loinc.org/LL380-7/)to enforce Onconova-compatible codes 

* [Expected Drug Effects](ValueSet-onconova-vs-expected-drug-effects.md) 
A value set of expected drug effects. 

* [Exposure Agents](ValueSet-onconova-vs-exposure-agents.md) 
Agents to which a patient may have been exposed. 

* [ICD-10 Codes](ValueSet-onconova-vs-icd-10-conditions.md) 
This value set includes sample ICD-10 codes. 

* [ICD-O-3 Differentiation](ValueSet-onconova-vs-icdo3-differentiation.md) 
A value set of ICD-O-3 differentiation codes. 

* [ICD-O-3 Morphology Behavior](ValueSet-onconova-vs-icdo3-morphology-behavior.md) 
A value set of ICD-O-3 morphology behavior codes. 

* [ICD-O-3 Topography](ValueSet-onconova-vs-icdo3-topography.md) 
A value set of ICD-O-3 topography codes. 

* [Observation Body Sites Value Set](ValueSet-onconova-vs-observation-bodysites.md) 
Bodysites related to an observation 

* [Recreational Drugs](ValueSet-onconova-vs-recreational-drugs.md) 
Substances that people use to alter their mental state, often for pleasure or leisure, with effects ranging from relaxation and euphoria to hallucinations and altered perceptions. 

* [Recurrence Type Value Set](ValueSet-onconova-vs-recurrence-type.md) 
A value set representing the types of cancer recurrence, specifically local and regional recurrences. 

* [Smoking status](ValueSet-onconova-vs-smoking-status.md) 
Smoking status of a patient 

* [TNM Distant Metastasis Categories Value Set](ValueSet-onconova-vs-tnm-distant-metastasis-categories.md) 
TNM Distant Metastasis Categories Value Set 

* [TNM Grade Categories Value Set](ValueSet-onconova-vs-tnm-grade-categories.md) 
TNM Grade Categories Value Set 

* [TNM Grade Category Methods Value Set](ValueSet-onconova-vs-tnm-grade-category-methods.md) 
TNM Grade Category Methods Value Set 

* [TNM Primary Tumor Categories](ValueSet-onconova-vs-tnm-primary-tumor-categories.md) 
TNM Primary Tumor Categories Value Set 

* [TNM Regional Nodes Categories Value Set](ValueSet-onconova-vs-tnm-regional-nodes-categories.md) 
TNM Regional Nodes Categories Value Set 

* [TNM Serum Tumor Marker Level Categories Value Set](ValueSet-onconova-vs-tnm-serum-tumor-marker-level-categories.md) 
TNM Serum Tumor Marker Level Categories Value Set 

* [TNM Venous Invasion Categories Value Set](ValueSet-onconova-vs-tnm-venous-invasion-categories.md) 
TNM Venous Invasion Categories Value Set 

* [Treatment Termination Reasons](ValueSet-onconova-vs-treatment-termination-reasons.md) 
Codes representing reasons for terminating a treatment in oncology. 

* [Tumor Board Recommendations](ValueSet-onconova-vs-tumor-board-recommendations.md) 
A value set of recommendations that may be made by a tumor board for a cancer patient. 

* [Tumor Marker Analytes](ValueSet-onconova-vs-tumor-marker-analytes.md) 
Codes representing analytes for tumor markers. 

* [Vital Status Value Set](ValueSet-onconova-vs-vital-status.md) 
The vital status of a patient 

# Code Systems

The following code systems have been defined for this implementation guide:

* [Comorbidity Panels Code System](CodeSystem-onconova-cs-comorbidity-panels.md) 
A code system for comorbidity panels relevant to cancer patients. 

* [Consent Status Code System](CodeSystem-onconova-cs-consent-status.md) 
A code system for consent status relevant to Onconova patients. 

* [To Be Determined Codes](CodeSystem-onconova-cs-tbd.md) 
A code system for codes that are yet to be determined. 

